Izotropic Corp logo

Izotropic Corp

NEW
FRA:1R3 (Canada)  
€ 0.14 -0.014 (-8.97%) Jul 8
At Loss
Market Cap:
€ 10.45M ($ 11.95M)
Enterprise V:
€ 12.17M ($ 13.91M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Izotropic Corp is a research and development company specializing in cancer research and early detection for breast cancer. It is engaged in advancing breast cancer imaging through the commercialization of medical imaging technologies. The company's current focus is on the commercialization of its first medical imaging device, IzoView, a dedicated Breast CT Imaging System, developed to provide high resolution, true 3D volumetric visualization of the breast without compression for breast cancer detection and diagnosis.
Name Current Vs Industry Vs History
Cash-To-Debt
0.12
Equity-to-Asset
-7.8
Debt-to-Equity
-0.59
Debt-to-EBITDA
-1.4
Piotroski F-Score
2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
42.97
9-Day RSI
48.07
14-Day RSI
48.91
3-1 Month Momentum %
23.02
6-1 Month Momentum %
-7.19
12-1 Month Momentum %
18.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.09
Quick Ratio
0.09
Cash Ratio
0.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-12.8
Shareholder Yield %
-8.92
Name Current Vs Industry Vs History
ROA %
-590.27
ROIC %
-91.41
3-Year ROIIC %
596.47
ROC (Joel Greenblatt) %
-6244.51
Moat Score
3
Tariff Resilience Score
7

GF Value Rank

Name Current Vs Industry Vs History
Forward PE Ratio
2.29
EV-to-EBIT
-8.65
EV-to-EBITDA
-8.78
EV-to-Forward-Revenue
1.39
EV-to-FCF
-23.34
Earnings Yield (Greenblatt) %
-11.55
FCF Yield %
-5.69

Financials

FRA:1R3's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Izotropic Corp Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.018
Beta 1.4031
3-Year Sharpe Ratio 0.37
3-Year Sortino Ratio 1.09
Volatility % 76.84
14-Day RSI 48.91
14-Day ATR (€) 0.006905
20-Day SMA (€) 0.1392
12-1 Month Momentum % 18.32
52-Week Range (€) 0.1 - 0.28
Shares Outstanding (Mil) 68.98

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Izotropic Corp Filings

Filing Date Document Date Form
No Filing Data

Izotropic Corp Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Izotropic Corp Frequently Asked Questions

What is Izotropic Corp(FRA:1R3)'s stock price today?
The current price of FRA:1R3 is €0.14. The 52 week high of FRA:1R3 is €0.28 and 52 week low is €0.10.
When is next earnings date of Izotropic Corp(FRA:1R3)?
The next earnings date of Izotropic Corp(FRA:1R3) is .
Does Izotropic Corp(FRA:1R3) pay dividends? If so, how much?
Izotropic Corp(FRA:1R3) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on Izotropic Corp

No articles.